Substituted sulfonamidobenzamides, antiarrhythmic agents and...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

260/291.4, 260/3

C07D 295/18 (2006.01) C07D 295/13 (2006.01) C07D 295/14 (2006.01)

Patent

CA 1246562

ABSTRACT OF THE DISCLOSURE Substituted sulfonamidobenzamides useful as antiarrhythmic agents having the formula Image I wherein R is lower alkyl, C3-C6-cycloalkyl, C3-C6-cycloalkyl (lower) alkyl, benzyl, or benzyl substituted by halogen, loweralkyl, loweralkoxy, or lower alkyl substituted by hydroxy, lower alkoxy, carbamoyl, N-loweralkylcarbamoyl, N,N-di-lower- alkylcarbamoyl and sulfamoyl; X and X1 are hydrogen and halogen; R1 is hydrogen, loweralkyl, unsaturated loweralkyl, loweralkoxy- loweralkyl, or collectively with R2 is an alkylene chain forming an azetidine, pyrrolidine, piperidine, or hexahydroazepine ring, or collectively with R3 is a bond or an alkylene chain forming an azetidine, pyrrolidine, piperidine or a hexahydroazepine ring, or collectively with R5 may produce a piperazine or a hexahydro-1,4- diazepine ring system; R2 is hydrogen, loweralkyl or collectively with R3 is a bond or an alkylene chain to form a saturated carbocylic ring or from 4 to 8 ring carbon atoms, R3 and R4 are hydrogen, loweralkyl or collectively is an alkylene chain forming a saturated carbocyclic ring of from 4 to 6 ring carbon atoms; R5 and R6 are hydrogen, loweralkyl, unsaturated loweralkyl, C1-C12 straight or branched chain alkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl(lower)alkyl, or when taken together form a saturated heterocyclic ring of from 4 to 8 ring members which may be substituted by one or more methyl groups or may contain a -O-, or Image linkage wherein p is the integer 0, 1 or 2; R6 is loweralkyl substituted by phenyl which may be substituted by up to 3 sub- stitutents selected from hydroxy or methoxy groups; n is 0, 1 or 2; or a pharmaceutically acceptable salt thereof; with the provisos that; (a) R5 and R6 are not both hydrogen, (b) when either R5 or R6 is hydrogen then the other is a C5-C10 straight or branched chain alkyl, cycloalkyl, cycloalkyl lower alkyl or lower alkyl substituted by phenyl which may be substituted by up to 3 substituents selected from hydroxy or methoxy groups, (c) when any of R1 , R5 and R6 is unsaturated loweralkyl, the unsaturation is other than alpha to the nitrogen atom. Their use in the treatment of cardiac arrhythmias, especially re-entrant arrhythmias, via the prolongation of the action potential of cardiac tissue is provided. Pharmaceutical formulations containing such compounds are also disclosed.

476879

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Substituted sulfonamidobenzamides, antiarrhythmic agents and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted sulfonamidobenzamides, antiarrhythmic agents and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted sulfonamidobenzamides, antiarrhythmic agents and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1175455

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.